Ronnie Mease

Associate Professor

1984 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Positron-Emission Tomography Medicine & Life Sciences
Radiopharmaceuticals Medicine & Life Sciences
Glutamate Carboxypeptidase II Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Urea Medicine & Life Sciences
Imaging techniques Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2018

Low-level endogenous PSMA expression in nonprostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging

Nimmagadda, S., Pullambhatla, M., Chen, Y., Parsana, P., Lisok, A., Chatterjee, S., Mease, R., Rowe, S. P., Lupold, S., Pienta, K. J. & Pomper, M. G., Mar 1 2018, In : Journal of Nuclear Medicine. 59, 3, p. 486-493 8 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Optical Imaging

Radioligand Therapy of Prostate Cancer with a Long-lasting PSMA Targeting Agent 90Y-DOTA-EB-MCG

Wang, Z., Jacobson, O., Tian, R., Mease, R. C., Kiesewetter, D., Niu, G., Pomper, M. G. & Chen, X., Apr 27 2018, (Accepted/In press) In : Bioconjugate Chemistry.

Research output: Contribution to journalArticle

Government data processing
Evans Blue
Prostatic Neoplasms

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation with Multiparametric MRI and Histopathology

Turkbey, B., Mena, E., Lindenberg, L., Adler, S., Bednarova, S., Berman, R., Ton, A. T., McKinney, Y., Eclarinal, P., Hill, C., Afari, G., Bhattacharyya, S., Mease, R. C., Merino, M. J., Jacobs, P. M., Wood, B. J., Pinto, P. A., Pomper, M. G. & Choyke, P. L., Oct 1 2017, In : Clinical Nuclear Medicine. 42, 10, p. 735-740 6 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Prostatic Hyperplasia
Health Insurance Portability and Accountability Act
Neoplasm Grading

A PSMA-targeted theranostic agent for photodynamic therapy

Chen, Y., Chatterjee, S., Lisok, A., Minn, I., Pullambhatla, M., Wharram, B., Wang, Y., Jin, J., Bhujwalla, Z. M., Nimmagadda, S., Mease, R. C. & Pomper, M. G., Feb 1 2017, In : Journal of Photochemistry and Photobiology B: Biology. 167, p. 111-116 6 p.

Research output: Contribution to journalArticle


Clinical impact of PSMA-based 18F–DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy

Mena, E. , Lindenberg, M. L. , Shih, J. H. , Adler, S. , Harmon, S. , Bergvall, E. , Citrin, D. , Dahut, W. , Ton, A. T. , McKinney, Y. , Weaver, J. , Eclarinal, P. , Forest, A. , Afari, G. , Bhattacharyya, S. , Mease, R. C. , Merino, M. J. , Pinto, P. , Wood, B. J. , Jacobs, P. & 3 others Pomper, M. G., Choyke, P. L. & Turkbey, B., Sep 11 2017, (Accepted/In press) In : European Journal of Nuclear Medicine and Molecular Imaging. p. 1-8 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Research Ethics Committees